Finally Time to Buy This Major Drug Manufacturer?

A couple of weeks ago, I was getting ready to pick up one of the world’s largest drug manufacturers Bristol-Myers Squibb (BMY) due to a recent 20% stock price plunge from a failed final stage lung cancer treatment trial. The time to accumulate BMY stock is finally getting close as volume seems to remain high…

Continue Reading →